Your session is about to expire
← Back to Search
Cervical Cancer Screening Program for Asian American Women
N/A
Recruiting
Led By Carolyn Y Fang, PhD
Research Sponsored by Fox Chase Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Are 30-65 years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
Study Summary
This trial will evaluate whether providing a self-sampling kit along with an educational program and navigation assistance increases cervical cancer screening rates in underserved Korean and Vietnamese American women.
Who is the study for?
This trial is for Korean or Vietnamese American women aged 30-65 who are overdue for cervical cancer screening and have not had a recent cytology-based screen or HPV test. It's not open to those with previous cervical abnormalities, those who've had their cervix removed, anyone with compromised immunity like HIV, or if they can't consent.Check my eligibility
What is being tested?
The study tests whether adding a self-sampling kit for HPV testing to an educational program and navigation assistance increases cervical cancer screening rates in the target group compared to just education and assistance.See study design
What are the potential side effects?
Since this trial involves non-invasive interventions such as education, navigation assistance, and self-sampling kits for HPV testing, there are minimal expected side effects. However, discomfort or emotional distress from the self-collection process cannot be ruled out.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 30 and 65 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Participation in screening
Secondary outcome measures
Program delivery cost
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: HPV Self-SamplingExperimental Treatment3 Interventions
Previously tested evidence-based intervention (i.e. culturally appropriate educational intervention focused on cervical cancer screening, with navigation assistance provided). Participants will also receive a self-sampling kit.
Group II: Evidence-Based InterventionActive Control2 Interventions
Culturally appropriate educational intervention focused on cervical cancer screening, with navigation assistance provided.
Find a Location
Who is running the clinical trial?
Temple UniversityOTHER
297 Previous Clinical Trials
82,173 Total Patients Enrolled
Fox Chase Cancer CenterLead Sponsor
227 Previous Clinical Trials
36,709 Total Patients Enrolled
Carolyn Y Fang, PhDPrincipal InvestigatorFox Chase Cancer Center
1 Previous Clinical Trials
50 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I haven't had a cervical cancer screening in the recommended time frame.I have been diagnosed with cervical cancer or a cervical abnormality before.Only women who are of Asian race and identify themselves as Korean or Vietnamese are eligible to participate.I am unable to understand and give consent for treatment.I am between 30 and 65 years old.I have had my uterus and cervix removed.
Research Study Groups:
This trial has the following groups:- Group 1: HPV Self-Sampling
- Group 2: Evidence-Based Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What criteria must be met for individuals to partake in this experiment?
"This clinical trial seeks 800 participants who have uterine cervical neoplasms, aged 30-65. Specifically, the study requires that potential enrollees are of Asian descent and define themselves as either Korean or Vietnamese."
Answered by AI
What is the upper threshold of participants in this clinical research?
"Affirmative. The details hosted on clinicaltrials.gov highlight that this medical study, which was initially posted on April 8th 2021, is presently accepting participants. A total of 800 individuals need to be enlisted at one location for the trial's completion."
Answered by AI
Does the current protocol include participants under 30 years of age?
"This trial is open to adults aged between 30 and 65 years old."
Answered by AI
Are volunteers still being admitted to this research study?
"Affirmative, clinicaltrials.gov reveals that this medical research project is currently recruiting. It was first posted on April 8th 2021 and updated recently on September 15th 2022; it requires 800 participants from 1 site to take part in the trial."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger